Michael Scolaro

Michael Scolaro

Oct 18, 2017

Group 6 Copy 34
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Circulating biomarkers of fibrosis in captive gorillas: a pilot study

    Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Can we make anesthesia for dogs safer with the help of nutrition?

    Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

    Backer Badge Funded